SG10202007719TA - Compositions, methods and uses for inducing viral growth - Google Patents
Compositions, methods and uses for inducing viral growthInfo
- Publication number
- SG10202007719TA SG10202007719TA SG10202007719TA SG10202007719TA SG10202007719TA SG 10202007719T A SG10202007719T A SG 10202007719TA SG 10202007719T A SG10202007719T A SG 10202007719TA SG 10202007719T A SG10202007719T A SG 10202007719TA SG 10202007719T A SG10202007719T A SG 10202007719TA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- methods
- viral growth
- inducing viral
- inducing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12026208P | 2008-12-05 | 2008-12-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202007719TA true SG10202007719TA (en) | 2020-09-29 |
Family
ID=42231513
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202007719TA SG10202007719TA (en) | 2008-12-05 | 2009-12-04 | Compositions, methods and uses for inducing viral growth |
| SG2011040961A SG171972A1 (en) | 2008-12-05 | 2009-12-04 | Compositions, methods and uses for inducing viral growth |
| SG10201503671TA SG10201503671TA (en) | 2008-12-05 | 2009-12-04 | Compositions, methods and uses for inducing viral growth |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2011040961A SG171972A1 (en) | 2008-12-05 | 2009-12-04 | Compositions, methods and uses for inducing viral growth |
| SG10201503671TA SG10201503671TA (en) | 2008-12-05 | 2009-12-04 | Compositions, methods and uses for inducing viral growth |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US8871487B2 (en) |
| EP (1) | EP2366024B1 (en) |
| JP (2) | JP5728742B2 (en) |
| KR (1) | KR101784951B1 (en) |
| CN (2) | CN105219734B (en) |
| AR (1) | AR074483A1 (en) |
| AU (1) | AU2009322175B2 (en) |
| BR (2) | BRPI0922788B8 (en) |
| CA (1) | CA2745962C (en) |
| CO (1) | CO6390063A2 (en) |
| CU (1) | CU20110128A7 (en) |
| HR (1) | HRP20191324T1 (en) |
| IL (2) | IL213389B (en) |
| MX (2) | MX2011005886A (en) |
| MY (1) | MY178195A (en) |
| NZ (1) | NZ593415A (en) |
| SG (3) | SG10202007719TA (en) |
| TW (2) | TWI573874B (en) |
| WO (1) | WO2010065911A1 (en) |
| ZA (2) | ZA201104364B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10202007719TA (en) * | 2008-12-05 | 2020-09-29 | Takeda Vaccines Inc | Compositions, methods and uses for inducing viral growth |
| EP2746386A1 (en) * | 2012-12-21 | 2014-06-25 | Lonza Cologne GmbH | Materials and methods for cell culture |
| SG11201707858TA (en) * | 2015-03-30 | 2017-10-30 | Ajinomoto Kk | Human serum albumin-containing culture medium for growth of neural stem cells |
| WO2023147342A2 (en) * | 2022-01-25 | 2023-08-03 | Takeda Vaccines, Inc. | Large-scale flaviviral vaccine production and manufacture |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5024947A (en) | 1987-07-24 | 1991-06-18 | Cetus Corporation | Serum free media for the growth on insect cells and expression of products thereby |
| US5616487A (en) * | 1994-09-15 | 1997-04-01 | Aastrom Biosciences, Inc. | Stabilized retrovirus compositions |
| EP0953041A4 (en) * | 1996-08-30 | 2003-01-29 | Life Technologies Inc | Serum-free mammalian cell culture medium, and uses thereof |
| ID19548A (en) * | 1996-09-24 | 1998-07-23 | Bavarian Nordic Res Inst As | RECOMBINED MVA VIRUSES EXPRESSING FEATURES ANTIGENS AND FEVER USING THEMS IN VACCINES |
| US7732129B1 (en) * | 1998-12-01 | 2010-06-08 | Crucell Holland B.V. | Method for the production and purification of adenoviral vectors |
| CA2382919C (en) | 1999-10-08 | 2008-12-09 | Gruenenthal Gmbh | Bicyclic imidazo-3-yl-amine derivatives |
| ATE526411T1 (en) * | 2000-02-16 | 2011-10-15 | Us Gov Health & Human Serv | AVIRULENT IMMUNOGENIC FLAVIVIRUS CHIMERA |
| US20030180329A1 (en) * | 2002-01-15 | 2003-09-25 | Monath Thomas P. | Viral vaccine production method |
| AU2003220531B2 (en) * | 2002-03-29 | 2007-11-01 | Merck & Co., Inc. | Large scale methods of producing adenovirus and adenovirus seed stocks |
| RU2237065C2 (en) | 2002-10-03 | 2004-09-27 | Государственный научный центр вирусологии и биотехнологии "Вектор" | Chimeric peptide immunogenic library mimicking genetic diversity of hypervariable region of protein v3 of human immunodeficiency virus envelope gp120 |
| PL199642B1 (en) * | 2002-11-15 | 2008-10-31 | Inst Immunologii I Terapii Do | High stability bacteriophage preparation and application of block copolymer of ethyl oxide and propylene oxide |
| US20100068147A1 (en) * | 2006-10-05 | 2010-03-18 | Agency for Science , Technology and Research | Dengue diagnosis and treatment |
| SG10201508397VA (en) * | 2007-04-06 | 2015-11-27 | Takeda Vaccines Inc | Methods and compositions for live attenuated viruses |
| US8367370B2 (en) * | 2008-02-11 | 2013-02-05 | Wheeler Aaron R | Droplet-based cell culture and cell assays using digital microfluidics |
| SG10202007719TA (en) * | 2008-12-05 | 2020-09-29 | Takeda Vaccines Inc | Compositions, methods and uses for inducing viral growth |
-
2009
- 2009-12-04 SG SG10202007719TA patent/SG10202007719TA/en unknown
- 2009-12-04 BR BRPI0922788A patent/BRPI0922788B8/en active IP Right Grant
- 2009-12-04 AU AU2009322175A patent/AU2009322175B2/en active Active
- 2009-12-04 TW TW103132644A patent/TWI573874B/en active
- 2009-12-04 KR KR1020117015005A patent/KR101784951B1/en active IP Right Grant
- 2009-12-04 CN CN201510470646.0A patent/CN105219734B/en active Active
- 2009-12-04 BR BR122020015754A patent/BR122020015754B8/en active IP Right Grant
- 2009-12-04 US US12/631,629 patent/US8871487B2/en active Active
- 2009-12-04 SG SG2011040961A patent/SG171972A1/en unknown
- 2009-12-04 MY MYPI2011002552A patent/MY178195A/en unknown
- 2009-12-04 WO PCT/US2009/066848 patent/WO2010065911A1/en active Application Filing
- 2009-12-04 MX MX2011005886A patent/MX2011005886A/en active IP Right Grant
- 2009-12-04 CA CA2745962A patent/CA2745962C/en active Active
- 2009-12-04 JP JP2011539758A patent/JP5728742B2/en active Active
- 2009-12-04 EP EP09831233.3A patent/EP2366024B1/en active Active
- 2009-12-04 AR ARP090104712A patent/AR074483A1/en active IP Right Grant
- 2009-12-04 SG SG10201503671TA patent/SG10201503671TA/en unknown
- 2009-12-04 TW TW098141534A patent/TWI461536B/en active
- 2009-12-04 CN CN200980154016.5A patent/CN102272294B/en active Active
- 2009-12-04 NZ NZ593415A patent/NZ593415A/en unknown
-
2011
- 2011-06-03 MX MX2015008630A patent/MX353602B/en unknown
- 2011-06-05 IL IL213389A patent/IL213389B/en active IP Right Grant
- 2011-06-06 CU CU20110128A patent/CU20110128A7/en unknown
- 2011-06-10 ZA ZA2011/04364A patent/ZA201104364B/en unknown
- 2011-06-17 CO CO11076067A patent/CO6390063A2/en not_active Application Discontinuation
-
2014
- 2014-09-19 US US14/491,805 patent/US9890362B2/en active Active
-
2015
- 2015-03-12 JP JP2015049625A patent/JP6174066B2/en active Active
- 2015-05-14 IL IL238819A patent/IL238819A/en active IP Right Grant
-
2016
- 2016-01-26 ZA ZA2016/00550A patent/ZA201600550B/en unknown
-
2017
- 2017-12-28 US US15/856,770 patent/US20180251737A1/en not_active Abandoned
-
2019
- 2019-07-23 HR HRP20191324TT patent/HRP20191324T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1250936A1 (en) | Compositions and methods for treating viral infections | |
| ZA201006944B (en) | Compositions and methods for preparing and using same | |
| EP2244380A4 (en) | Predistorter | |
| ZA201203603B (en) | Lyophilization methods, compositions, and kits | |
| GB0807424D0 (en) | Virus | |
| GB0822068D0 (en) | Methods for virus design | |
| HK1215025A1 (en) | Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same --25- | |
| GB0706077D0 (en) | Methods, Compositions and uses thereof | |
| EP2285405A4 (en) | Vaccine compositions and methods | |
| ZA201600550B (en) | Compositions, methods and uses for inducing viral growth | |
| IL214211A0 (en) | Stable vaccine compositions and methods for preparing the same | |
| HRP20150021T1 (en) | Phenanthrenone compounds, compositions and methods | |
| GB0801122D0 (en) | Vaccine composition | |
| GB0823560D0 (en) | Virus | |
| GB0815069D0 (en) | Viral inactivation | |
| GB0802326D0 (en) | Vaccine Composition | |
| GB0813823D0 (en) | Virus | |
| GB0810378D0 (en) | Virus | |
| GB0803779D0 (en) | Viral inactivation process | |
| GB0811276D0 (en) | Viral inactivation process | |
| GB0901234D0 (en) | Composition,method and use | |
| GB0901227D0 (en) | Composition,method and use | |
| GB0901293D0 (en) | Composition, method and use | |
| AU2008905185A0 (en) | Methods and compositions for preparing hormone-depleted surem |